Yahoo Web Search

Search results

1. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 7 hours ago

     Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration ...

2. • New research platform assesses brain cancer mutations during surgery

     Medical Xpress· 2 days ago

     Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published ...

3. • 

     Mother backs Epsom Derby auction to honour daughter

     BBC via Yahoo News· 2 days ago

     Funds raised by the event will be used by the charity for research at its centres across the UK, with the aim of finding a cure for brain cancer. Emily,...

4. • 

     Gene therapy offers huge potential for combating disease, doctors say

     UPI· 2 days ago

     1 of 3 | Dr. Krystof Bankiewicz collaborates with his team in the lab at The Ohio State University...

5. • 

     Shawnee County family remembers daughter during brain cancer awareness month

     KSNT Topeka via Yahoo News· 6 days ago

     SHAWNEE COUNTY (KSNT) – May is National Brain Cancer Awareness Month and one local family is...

6. • Agios Pharma Stock Climbs On Royalty Pharma's Deal To Buy Royalty Stake In Vorasidenib

     RTT News· 5 days ago

     s vorasidenib for $905 million in upfront cash. The deal is contingent on the approval of vorasidenib by the U.S. Food and Drug Administration. In pre-market activity on the Nasdaq, Agios Pharma ...

7. • Candel Therapeutics Gets FDA's Orphan-Drug Status for Glioma Treatment

     Market Watch· 2 days ago

     By Dean Seal Candel Therapeutics said regulators have granted orphan-drug designation to its CAN-3110 drug candidate as a treatment for recurrent high-grade...

8. • Why Are Younger People Getting Cancer?

     US News Health· 3 days ago

     At age 20, while studying sports management and marketing in college, Sean Kukoleck's life was disrupted by cancer. Cancer screenings are happening at younger ages, especially for those at higher risk or a family history of cancer.

9. • 

     Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty

     Zacks via Yahoo Finance· 3 days ago

     Agios Pharmaceuticals (AGIO) agrees to sell to Royalty Pharma the rights to royalties on potential...

10. • TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders

      Morningstar· 6 days ago

      TME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment ...